What are the commercial (brand) names for commonly used medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Commercial (Brand) Names of Common Medications

The evidence provided focuses primarily on generic drug names and drug classes rather than comprehensive brand name listings, but several commercial names are explicitly mentioned across therapeutic categories.

Cardiovascular Medications

Statins

  • Lipitor (atorvastatin) 1
  • Simvastatin and lovastatin are mentioned but without specific brand names 1
  • Fluvastatin, rosuvastatin, and pitavastatin are referenced generically 1

Antihypertensive Agents

ACE Inhibitors:

  • Lotensin (benazepril) 2, 3
  • Capoten (captopril) 2, 3
  • Vasotec (enalapril) 2, 3
  • Monopril (fosinopril) 2, 3
  • Prinivil/Zestril (lisinopril) 2, 3
  • Univasc (moexipril) 2, 3
  • Aceon (perindopril) 2, 3
  • Accupril (quinapril) 2, 3
  • Altace (ramipril) 2, 3
  • Mavik (trandolapril) 2, 3

Angiotensin Receptor Blockers (ARBs):

  • Atacand (candesartan) 2, 3
  • Teveten (eprosartan) 2, 3
  • Avapro (irbesartan) 2, 3
  • Cozaar (losartan) 2, 3
  • Benicar (olmesartan) 2, 3
  • Micardis (telmisartan) 2, 3
  • Diovan (valsartan) 2, 3

Combination Products:

  • Lotrel (amlodipine-benazepril) 2
  • Prinzide/Zestoretic (lisinopril-hydrochlorothiazide) 2
  • Hyzaar (losartan-hydrochlorothiazide) 2
  • Diovan-HCT (valsartan-hydrochlorothiazide) 2
  • Tenoretic (atenolol-chlorthalidone) 2

Diabetes Medications

Oral Agents

  • Januvia (sitagliptin) - DPP-4 inhibitor 4, 5
  • Generic metformin is referenced extensively but without brand names 4

Injectable Agents

  • Valtrex (valacyclovir) - mentioned in ophthalmology context 6

Antiemetic Medications

NK1 Receptor Antagonists:

  • Rolapitant (approved 2015, brand name not specified) 7
  • Aprepitant (brand name not specified) 7

5-HT3 Antagonists:

  • Ondansetron (generic referenced) 7
  • Granisetron (generic referenced) 7
  • Palonosetron (generic referenced) 7

Weight Management Medications

  • Xenical/Alli (orlistat) - Xenical is 120mg prescription, Alli is 60mg over-the-counter 8
  • Phentermine/topiramate extended-release (brand name not specified) 8

Ophthalmology Medications

Glaucoma Treatments:

  • Timoptic (timolol) 6
  • Xalatan (latanoprost) 6
  • Alphagan (brimonidine) 6
  • Trusopt (dorzolamide) 6
  • Azopt (brinzolamide) 6
  • Cosopt (dorzolamide-timolol combination) 6

Anti-inflammatory:

  • Durezol (difluprednate) 6
  • Pred Mild (prednisolone) 6
  • Acuvail (ketorolac) 6
  • Ilevro (nepafenac) 6

Antibiotics:

  • Vigamox (moxifloxacin) 6
  • Cipro (ciprofloxacin) 6
  • Tobrex (tobramycin) 6
  • Zithromax (azithromycin) 6

Antiallergy:

  • Zaditor (ketotifen) 6

Important Caveats

Brand name confusion is a significant safety concern - identical or similar brand names may be used in different countries for medications with completely different active ingredients, creating potential for serious medication errors 9, 10. Healthcare providers should always verify both brand and generic names when prescribing or dispensing medications 9.

Generic substitution is strongly encouraged when clinically appropriate, as it can result in substantial cost savings without compromising efficacy for most medication classes 5. The evidence suggests generic medications are generally bioequivalent to brand names, though some studies have raised questions about stability and particulate content in certain generic formulations 11.

References

Research

Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2018

Guideline

practical use of pharmacotherapy for obesity.

Gastroenterology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.